Pharmaceuticals (124) | Termination Agreements (2,698)

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Acer Therapeutics Inc. (2)
ACHILLION PHARMACEUTICALS INC (1)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (1)
Allergan, plc (1)
Altus Pharmaceuticals Inc. (2)
Amag Pharmaceuticals (3)
Ampio Pharmaceuticals, Inc. (1)
AMYLIN PHARMACEUTICALS INC (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (1)
APRICUS BIOSCIENCES, INC. (2)
Assertio Therapeutics, Inc (2)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (1)
AVANIR PHARMACEUTICALS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (1)
AYTU BIOSCIENCE, INC (3)
Bespoke Extracts, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Bohai Pharmaceuticals Group, Inc. (1)
Bristol-Myers Squibb (1)
CADENCE PHARMACEUTICALS INC (2)
CASSAVA SCIENCES INC (1)
Celator Pharmaceuticals Inc (1)
Cocrystal Pharma, Inc. (1)
Context Therapeutics Inc. (1)
Cronos Group Inc. (2)
ELITE PHARMACEUTICALS INC (1)
ENCYSIVE PHARMACEUTICALS INC (3)
Exactus, Inc. (1)
FERMAVIR PHARMACEUTICALS, INC. (2)
Foamix Pharmaceuticals Ltd. (2)
GB SCIENCES INC (1)
HARROW HEALTH, INC. (2)
IDENIX PHARMACEUTICALS INC (1)
Innoviva, Inc. (2)
Intra-Cellular Therapies, Inc. (1)
Jaguar Health, Inc. (3)
Jazz Pharmaceuticals plc (1)
JUNIPER PHARMACEUTICALS INC (1)
Kedem Pharmaceuticals Inc. (1)
KING PHARMACEUTICALS INC (1)
Level Brands, Inc. (1)
Luckwel Pharmaceuticals Inc. (2)
Melt Pharmaceuticals, Inc. (1)
Menlo Therapeutics Inc. (1)
Merck (1)
MJ Holdings, Inc. (5)
MYnd Analytics, Inc. (2)
MyoKardia Inc (1)
NEKTAR THERAPEUTICS (1)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (1)
NOVEN PHARMACEUTICALS INC (1)
NUCRYST Pharmaceuticals Corp. (1)
NURX PHARMACEUTICALS, INC. (1)
Onconova Therapeutics, Inc. (1)
OSCIENT PHARMACEUTICALS CORP (1)
Paratek Pharmaceuticals, Inc. (2)
PENWEST PHARMACEUTICALS CO (2)
Perrigo (1)
Pfizer (1)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
ProPhase Labs, Inc. (3)
QUESTCOR PHARMACEUTICALS INC (1)
Revance Therapeutics, Inc. (2)
Roivant Sciences Ltd. (1)
SALIX PHARMACEUTICALS LTD (2)
SCYNEXIS INC (4)
Sucampo Pharmaceuticals, Inc. (1)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
Theravance Biopharma, Inc. (1)
TIBET PHARMACEUTICALS, INC. (1)
Tongli Pharmaceuticals (USA), Inc. (2)
Trubion Pharmaceuticals, Inc (1)
Valera Pharmaceuticals Inc (4)
VIVUS INC (1)
XCEL PHARMACEUTICALS INC (1)
ZOGENIX, INC. (1)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (AYTU BIOSCIENCE, INC, Filed With SEC on May 11, 2023)
Termination Agreement of the Clinical Trial Collaboration and Supply Agreement, dated March 21, 2023 between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group (Context Therapeutics Inc., Filed With SEC on March 22, 2023)
Mutual Termination of License Agreement, dated as of January 31, 2023, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD, and Tao Wang (Jaguar Health, Inc., Filed With SEC on February 6, 2023)
Termination Agreement dated as of January 30, 2023 among Acer Therapeutics Inc., the Lenders party thereto and MAM Aardvark, LLC, not individually, but solely in its capacity as... (Acer Therapeutics Inc., Filed With SEC on January 31, 2023)
Termination Agreement (Bespoke Extracts, Inc., Filed With SEC on November 21, 2022)
Partial Termination and Supplementary Fee Agreement relating to the Clinical Supply Agreement and Commercial Supply Agreement, dated as of July 25, 2022, by and between... (Roivant Sciences Ltd., Filed With SEC on November 14, 2022)
Mutual Termination Agreement, dated October 7, 2022 between ImprimisRx and EyePoint Pharmaceuticals, Inc (HARROW HEALTH, INC., Filed With SEC on November 14, 2022)
Letter of Termination and Release Agreement, dated May 28, 2021, by and between the Registrant and Mark Hazard (Melt Pharmaceuticals, Inc., Filed With SEC on September 21, 2022)
Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (AYTU BIOSCIENCE, INC, Filed With SEC on May 16, 2022)
Termination Agreement dated March 3, 2022, by and between AXIM Biotechnologies, Inc. and Empowered Diagnostics, LLC (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on April 15, 2022)
Termination Agreement dated August 26, 2021 (MJ Holdings, Inc., Filed With SEC on October 7, 2021)
Termination Agreement, dated June 29, 2021 by and between Aytu BioPharma, Inc. and Avrio Genetics, LLC (AYTU BIOSCIENCE, INC, Filed With SEC on September 28, 2021)
Acknowledgment and Termination Agreement, dated as of June 14, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (APRICUS BIOSCIENCES, INC., Filed With SEC on June 17, 2021)
Termination Agreement between the Company, Blue Sky Companies, LLC and Lets Roll Nevada, LLC dated March 24, 2021 (MJ Holdings, Inc., Filed With SEC on April 15, 2021)
Fourth Amendment to Termination and License Agreement between SCYNEXIS, Inc. and Merck Sharp & Dohme Corp. dated December 2, 2020 (SCYNEXIS INC, Filed With SEC on March 29, 2021)
Termination Agreement dated March 2, 2021 (PLx Pharma Inc., Filed With SEC on March 2, 2021)
Notice of Termination dated January 21, 2021 (MJ Holdings, Inc., Filed With SEC on January 27, 2021)
Amendment and Termination Agreement, dated and effective as of January 14, 2021 (ProPhase Labs, Inc., Filed With SEC on January 15, 2021)
Termination and Mutual Release Agreement between MJ Holdings, Inc. and Healthier Choices Management Corp dated November 15, 2019 (MJ Holdings, Inc., Filed With SEC on December 10, 2020)
*** Certain identified information hasbeen omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrantif publicly... (Adamis Pharmaceuticals Corp, Filed With SEC on August 17, 2020)
Termination Agreement, dated (Amag Pharmaceuticals, Filed With SEC on July 27, 2020)
Termination of Employment Agreement and Release, dated as of March 22, 2020, by and between Foamix Pharmaceuticals Ltd. and Ilan Hadar (Menlo Therapeutics Inc., Filed With SEC on May 11, 2020)
Termination and Release Agreement, by and among Cronos Group Inc. and David Hsu, dated as of November 15, 2019 (Cronos Group Inc., Filed With SEC on March 2, 2020)
Termination and Release Agreement, by and among Cronos Group Inc. and William Lawrence Hilson, dated as of November 15, 2019 (Cronos Group Inc., Filed With SEC on March 2, 2020)
Termination Agreement, effective December 31, 2019, by and between Svend Andersen and Wrafton Laboratories Limited (Perrigo, Filed With SEC on February 27, 2020)
Termination Agreement among Trava LLC, the Company, EWSD I LLC, and Pueblo Agriculture Supply and Equipment LLC, dated January 29, 2018 (Notis Global, Inc., Filed With SEC on November 27, 2019)
Termination Agreement, by and between the Registrant and Aventis, Inc. dated July 17, 2019 (MyoKardia Inc, Filed With SEC on November 4, 2019)
Termination of Distribution and Supply Agreement, dated as of August 6, 2019, by and between AMAG Pharmaceuticals, Inc. and Prasco, LLC (Amag Pharmaceuticals, Filed With SEC on November 1, 2019)
License Termination and Settlement Agreement, dated October 1, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Michael Tempesta (Jaguar Health, Inc., Filed With SEC on October 7, 2019)
AMENDMENT AND TERMINATION AGREEMENT (GB SCIENCES INC, Filed With SEC on July 15, 2019)
Pain Therapeutics, Inc. termination notice to Durect Corporation dated March 20, 2019 (CASSAVA SCIENCES INC, Filed With SEC on March 22, 2019)
Termination Agreement and Mutual Release with James R. Erickson (Exactus, Inc., Filed With SEC on February 22, 2019)
Mutual Termination of License Agreement dated January 07, 2019 by and between Level Brands, Inc. and Isodiol International, Inc (Level Brands, Inc., Filed With SEC on January 11, 2019)
Employment Termination and Release Agreement, dated December 30, 2018, between Avadel Management Corporation, Avadel Pharmaceuticals plc and Michael S. Anderson (AVADEL PHARMACEUTICALS PLC, Filed With SEC on January 3, 2019)
Suspension, Settlement and Termination Agreement, dated December 4, 2018, by and among Napo Pharmaceuticals, Inc., Jaguar Health, Inc. and SmartPharma, LLC (Jaguar Health, Inc., Filed With SEC on December 10, 2018)
Termination of Agreement and Release dated September 30, 2018, by and between MJ Holdings, Inc. and Profesco, Inc (MJ Holdings, Inc., Filed With SEC on November 15, 2018)
Amendment and Termination of Rights Agreement, dated as of May 1, 2018, between the Company and Computershare Inc (Theravance Biopharma, Inc., Filed With SEC on May 1, 2018)
Termination Agreement of Mr. Meir Eini, effective as of July 1, 2017 (Foamix Pharmaceuticals Ltd., Filed With SEC on February 27, 2018)
Termination Agreement of Dr. Dov Tamarkin, effective as of July 1, 2017 (Foamix Pharmaceuticals Ltd., Filed With SEC on February 27, 2018)
Termination Agreement, dated as of January 25, 2018, between Teva Pharmaceuticals Europe B.V. and Rob Koremans (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on February 12, 2018)